COVID19 biomarkers: What did we learn from systematic reviews?
S Semiz - Frontiers in cellular and infection microbiology, 2022 - frontiersin.org
The coronavirus disease 2019 (COVID19) pandemic continues to represent a substantial
public health concern. It can rapidly progress to severe disease, with poor prognosis and a …
public health concern. It can rapidly progress to severe disease, with poor prognosis and a …
Procalcitonin as a predictive marker in COVID-19: A systematic review and meta-analysis
Background Coronavirus disease 2019 has emerged as a global pandemic causing millions
of critical cases and deaths. Early identification of at-risk patients is crucial for planning …
of critical cases and deaths. Early identification of at-risk patients is crucial for planning …
Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-19
S Wolfisberg, C Gregoriano… - Critical reviews in clinical …, 2022 - Taylor & Francis
Procalcitonin (PCT) is useful for differentiating between viral and bacterial infections and for
reducing the unnecessary use of antibiotics. As the rise of antimicrobial resistance reaches …
reducing the unnecessary use of antibiotics. As the rise of antimicrobial resistance reaches …
COVID-19 severity and mortality in two pandemic waves in Poland and predictors of poor outcomes of SARS-CoV-2 infection in hospitalized young adults
L Ziuzia-Januszewska, M Januszewski… - Viruses, 2022 - mdpi.com
SARS-CoV-2 variants pose a significant threat to global public health. However, their
influence on disease severity, especially among young adults who may exhibit different …
influence on disease severity, especially among young adults who may exhibit different …
[HTML][HTML] Role of procalcitonin as a predictor of clinical outcomes in hospitalized patients with COVID-19
I Jackson, H Jaradeh, S Aurit, A Aldamen… - International Journal of …, 2022 - Elsevier
Objectives In this study, we aimed to determine the correlation between procalcitonin (PCT)
levels and clinical outcomes including in-hospital mortality, intensive care unit (ICU) length …
levels and clinical outcomes including in-hospital mortality, intensive care unit (ICU) length …
[PDF][PDF] A bibliometric analysis of coronavirus disease (COVID-19) mortality rate
Husnul Khuluq 1*, Prasandhya Astagiri Yusuf 2, Dyah Aryani Perwitasari 3 Background:
Coronavirus disease 2019 (COVID-19) has had a profound global effect on mortality rates …
Coronavirus disease 2019 (COVID-19) has had a profound global effect on mortality rates …
Serum procalcitonin level is independently associated with mechanical ventilation and case-fatality in hospitalized COVID-19-positive US veterans–A potential marker …
S Jeyapalina, G Wei, GJ Stoddard, JD Sudduth… - PloS One, 2023 - journals.plos.org
The Coronavirus-19 disease (COVID-19) has claimed over 6.8 million lives since first being
reported in late 2019. The virus that causes COVID-19 disease is highly contagious and …
reported in late 2019. The virus that causes COVID-19 disease is highly contagious and …
Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID‐19 in people with SARS‐CoV‐2
L De Rop, DAG Bos, I Stegeman… - Cochrane Database …, 2024 - cochranelibrary.com
Background Identifying patients with COVID‐19 disease who will deteriorate can be useful
to assess whether they should receive intensive care, or whether they can be treated in a …
to assess whether they should receive intensive care, or whether they can be treated in a …
Serum Human Epididymis Protein-4 Outperforms Conventional Biomarkers in Early Detection of Non-Small Cell Lung Cancer
ME Zare, AN Kansestani, X Wu, L Zhou, J Lu, J Huang… - iScience, 2024 - cell.com
We employed a three-step approach to evaluate serum immunoassay-based biomarkers for
detecting non-small cell lung cancer (NSCLC). In the first step, we performed a systematic …
detecting non-small cell lung cancer (NSCLC). In the first step, we performed a systematic …
Serum Krebs von den Lungen-6 for Predicting the Severity of COVID-19: A Systematic Review, Meta-Analysis, and Trial Sequence Analysis
AB Shrestha, P Pokharel, H Singh… - Clinical Medicine …, 2023 - journals.sagepub.com
OBJECTIVE This systematic review and meta-analysis aimed to find the association
between serum Krebs von den Lungen-6 (KL-6) and the severity of Coronavirus disease …
between serum Krebs von den Lungen-6 (KL-6) and the severity of Coronavirus disease …